Skip to main content

1 article related to "Her3 Inhibitors"

No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.

Articles

General Commentary

Published on 13 Mar 2017

Commentary: Randomized Phase II Study of Duligotuzumab (MEHD7945A) vs. Cetuximab in Squamous Cell Carcinoma of the Head and Neck (MEHGAN Study)

in Head and Neck Cancer

Nabil F. Saba

Frontiers in Oncology

doi 10.3389/fonc.2017.00031

3,508 views
10 citations